Record Information |
---|
Version | 2.0 |
---|
Created at | 2022-09-10 21:07:50 UTC |
---|
Updated at | 2022-09-10 21:07:50 UTC |
---|
NP-MRD ID | NP0305359 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | (2s)-2-[(4-{[(5-formyl-4-hydroxy-2-imino-1,6,7,8-tetrahydropteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic acid |
---|
Description | Leucovorin, also known as folinate or folinic acid, belongs to the class of organic compounds known as glutamic acid and derivatives. Glutamic acid and derivatives are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. A formyltetrahydrofolic acid in which the formyl group is located at position 5. Leucovorin is a drug which is used for the treatment of osteosarcoma (after high dose methotrexate therapy). Used to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosages of folic acid antagonists, and to treat megaloblastic anemias due to folic acid deficiency. Also used in combination with 5-fluorouracil to prolong survival in the palliative treatment of patients with advanced colorectal cancer. Leucovorin is a moderately basic compound (based on its pKa). (2s)-2-[(4-{[(5-formyl-4-hydroxy-2-imino-1,6,7,8-tetrahydropteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic acid is found in Capsicum annuum and Mus musculus. In humans, leucovorin is involved in the metabolic disorder called the methylenetetrahydrofolate reductase deficiency (mthfrd) pathway. |
---|
Structure | NC1=NC(=O)C2=C(NCC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2C=O)N1 InChI=1S/C20H23N7O7/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32)/t12?,13-/m0/s1 |
---|
Synonyms | Value | Source |
---|
(5-Formyl-5,6,7,8-tetrahydropteroyl)glutamate | ChEBI | 10-Formyl-7,8-dihydrofolic acid | ChEBI | 5-Formyl-5,6,7,8-tetrahydrofolic acid | ChEBI | 5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid | ChEBI | 5-Formyltetrahydrofolate | ChEBI | Acide folinique | ChEBI | Folinate | ChEBI | Folinic acid | ChEBI | L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid | ChEBI | Leucovorinum | ChEBI | N-(5-Formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid | ChEBI | N5-Formyl-5,6,7,8-tetrahydrofolic acid | ChEBI | N5-Formyltetrahydrofolic acid | ChEBI | (5-Formyl-5,6,7,8-tetrahydropteroyl)glutamic acid | Generator | 10-Formyl-7,8-dihydrofolate | Generator | 5-Formyl-5,6,7,8-tetrahydrofolate | Generator | 5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamate | Generator | 5-Formyltetrahydrofolic acid | Generator | L(-)-5-Formyl-5,6,7,8-tetrahydrofolate | Generator | N-(5-Formyl-5,6,7,8-tetrahydropteroyl)-L-glutamate | Generator | N5-Formyl-5,6,7,8-tetrahydrofolate | Generator | N5-Formyltetrahydrofolate | Generator | Leucovorin | ChEBI | (2S)-2-[[4-[(2-amino-5-Formyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioate | Generator | 5-Formyltetrahydropteroylglutamate | MeSH | Calcium folinate | MeSH | Leucovorin, calcium (1:1) salt, (DL)-isomer | MeSH | Wellcovorin | MeSH | Acid, folinic | MeSH | Leukovorum | MeSH | Monosodium salt leucovorin | MeSH | 5 Formyltetrahydropteroylglutamate | MeSH | Calcium leucovorin | MeSH | Folinate, calcium | MeSH | Folinic acid SF | MeSH | Leucovorin, calcium (1:1) salt | MeSH | Leucovorin, calcium (1:1) salt, pentahydrate | MeSH | Factor, citrovorum | MeSH | N(5)-Formyltetrahydrofolate | MeSH | Citrovorum factor | MeSH | Leucovorin, calcium | MeSH | Leukovorin | MeSH | Leucovorin, (R)-isomer | MeSH | 5 Formyltetrahydrofolate | MeSH | Leucovorin, (DL)-isomer | MeSH | Folinic acid-SF | MeSH | Leucovorin, monosodium salt | MeSH | (6R,S)-5-Formyltetrahydrofolate | HMDB | 5-Formyltetrahydropteroylglutamic acid | HMDB | CF | HMDB | Kunyrin | HMDB | Leucoverin | HMDB | N5-Formyl-THF | HMDB | Welcovorin | HMDB | l-Leucovorin | HMDB |
|
---|
Chemical Formula | C20H23N7O7 |
---|
Average Mass | 473.4460 Da |
---|
Monoisotopic Mass | 473.16590 Da |
---|
IUPAC Name | (2S)-2-[(4-{[(2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic acid |
---|
Traditional Name | folinic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | NC1=NC(=O)C2=C(NCC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2C=O)N1 |
---|
InChI Identifier | InChI=1S/C20H23N7O7/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32)/t12?,13-/m0/s1 |
---|
InChI Key | VVIAGPKUTFNRDU-ABLWVSNPSA-N |
---|
Experimental Spectra |
---|
|
| Not Available | Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as glutamic acid and derivatives. Glutamic acid and derivatives are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Glutamic acid and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Glutamic acid or derivatives
- Hippuric acid or derivatives
- Hippuric acid
- N-acyl-alpha-amino acid
- N-acyl-alpha amino acid or derivatives
- Pterin
- Aminobenzamide
- Aminobenzoic acid or derivatives
- Pteridine
- Benzamide
- Benzoic acid or derivatives
- Benzoyl
- Phenylalkylamine
- Aniline or substituted anilines
- Secondary aliphatic/aromatic amine
- Hydroxypyrimidine
- Benzenoid
- Pyrimidine
- Monocyclic benzene moiety
- Dicarboxylic acid or derivatives
- Tertiary carboxylic acid amide
- Heteroaromatic compound
- Secondary carboxylic acid amide
- Carboxamide group
- Amino acid
- Organoheterocyclic compound
- Secondary amine
- Azacycle
- Carboxylic acid
- Organic oxygen compound
- Carbonyl group
- Amine
- Organic oxide
- Organic nitrogen compound
- Organopnictogen compound
- Organooxygen compound
- Organonitrogen compound
- Hydrocarbon derivative
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|